Cancerfonden

Next steps

Deadline: 15 December 2026 (93 days)

Last updated: 13 Sept 2026

Closes 15 Dec 2026. Add it to your calendar, then see what else you're eligible for. See my matches →

Cancerfonden's Next Steps grant funds late-stage cancer research (TRL 6-9) to move promising results toward patient benefit, commercialization, or implementation in Swedish healthcare. It requires a consortium including a utilisation or commercialisation partner to support industry uptake or clinical implementation, and is open to research groups based in Sweden. Cancerfonden runs this call annually.

Details

Funder	Cancerfonden
Deadline	15 December 2026
Consortium	Required — utilisation/commercialisation partner for implementation or industry uptake
TRL	6-9
Frequency	Annual
Eligible countries	SE

Eligibility & scope

Supports moving promising research results forward towards patient benefit, commercialisation or implementation in healthcare.

Who Should Apply

•Research teams with results at TRL 6-9, close to clinical or commercial application
•Applicants based at Swedish research institutions
•Projects targeting patient benefit, commercialization, or healthcare implementation
•Teams able to secure a utilisation or commercialisation partner (industry or implementation partner)

Key Dates

•Deadline: 15 December 2026
•Recurring annual call

Tips for Applicants

✓Secure and document your utilisation/commercialisation partner early, this consortium requirement is gating, not optional.
✓Frame the proposal around TRL progression: reviewers expect clarity on where the project sits between 6 and 9 and what milestone it reaches next.
✓Emphasise the pathway to patient benefit or industry uptake explicitly, since this distinguishes the call from earlier-stage discovery grants.

Frequently Asked Questions

What TRL level does the Cancerfonden Next Steps grant require?

Projects should be at TRL 6-9, meaning results are already demonstrated in relevant environments and moving toward real-world application.

Do I need a partner to apply for Next Steps?

Yes, a consortium including a utilisation or commercialisation partner for implementation or industry uptake is required.

Who is eligible for the Cancerfonden Next Steps grant?

Applicants must be based in Sweden, working on cancer research results ready to move toward patient benefit, commercialization, or healthcare implementation.

Is the Cancerfonden Next Steps grant a recurring call?

Yes, it runs annually, with the current deadline set for 15 December 2026.

cancer-biologycancerfondentranslational-researchcommercializationswedenlate-stage-trlindustry-partnershipconsortium-required

View full call →

Share ✉ Email X LinkedIn WhatsApp

Summary generated by AI based on published grant information. Always verify details on the funder's website.